The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Axon degeneration mechanisms: commonality amid diversity
Abstract
A wide range of insults can trigger axon degeneration, and axons respond with diverse morphology, topology and speed. However, recent genetic, immunochemical, morphological and pharmacological investigations point to convergent degeneration mechanisms. The principal convergence points - poor axonal transport, mitochondrial dysfunction and an increase in intra-axonal calcium - have been identified by rescuing axons with the slow Wallerian degeneration gene (Wld(S)) and studies with blockers of sodium or calcium influx. By understanding how the pathways fit together, we can combine our knowledge of mechanisms, and potentially also treatment strategies, from different axonal disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another important factor might be the disruption of fast axonal transport, resulting in focal swellings filled with various organelles, as seen in the vicinity but also distant from plaques in several AD transgenic models [27,28,29,30], resembling Wallerian degeneration [31].”
From Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models (2020) · cites this paper as [31]
In the citing paper
“The principal mechanisms of axon degeneration are metabolic stress, disturbed axonal transport, and mitochondrial dysfunction [301].”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [301]
Citations
Cites
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Imaging Neuronal Subsets in Transgenic Mice Expressing Multiple Spectral Variants of GFP
Feng, G., Mellor, R. H., Bernstein, M., Keller-Peck, C., Nguyen, Q. T., Wallace, M., Nerbonne, J. M., Lichtman, J. W., & Sanes, J. R. (2000) · Neuron · doi:10.1016/s0896-6273(00)00084-2 · Cited by 3,042
Axonal damage in acute multiple sclerosis lesions
Ferguson, B. (1997) · Brain · doi:10.1093/brain/120.3.393 · Cited by 1,532
Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man
Fischer, L. R., Culver, D. G., Tennant, P., Davis, A. A., Wang, M.-S., Castellano-Sanchez, A. A., Khan, J., Polak, M. A., & Glass, J. D. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.10.004 · Cited by 1,383
Death by design: apoptosis, necrosis and autophagy
Edinger, A. L., & Thompson, C. B. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.09.011 · Cited by 1,362
Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer’s Disease
Stokin, G. B., Lillo, C., Falzone, T. L., Brusch, R. G., Rockenstein, E., Mount, S. L., Raman, R., Davies, P., Masliah, E., Williams, D. S., et al. (2005) · Science · doi:10.1126/science.1105681 · Cited by 1,214
Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration
Araki, T., Sasaki, Y., & Milbrandt, J. (2004) · Science · doi:10.1126/science.1098014 · Cited by 1,060
Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination
Lappe-Siefke, C., Goebbels, S., Gravel, M., Nicksch, E., Lee, J., Braun, P. E., Griffiths, I. R., & Nave, K.-A. (2003) · Nature Genetics · doi:10.1038/ng1095 · Cited by 1,036
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
Sirén, A., Fratelli, M., Brines, M. L., Goemans, C. G., Casagrande, S., Lewczuk, P., Keenan, S., Gleiter, C. H., Pasquali, C., Capobianco, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051606598 · Cited by 1,019
Waller, A. V. (1850) · Philosophical Transactions of the Royal Society of London · doi:10.1098/rstl.1850.0021 · Cited by 889
Axonal Swellings and Degeneration in Mice Lacking the Major Proteolipid of Myelin
Griffiths, I., Klugmann, M., Anderson, T., Yool, D., Thomson, C., Schwab, M. H., Schneider, A., Zimmermann, F., McCulloch, M., Nadon, N., et al. (1998) · Science · doi:10.1126/science.280.5369.1610 · Cited by 889
Molecular motors and mechanisms of directional transport in neurons
Hirokawa, N., & Takemura, R. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1624 · Cited by 856
Charcot-Marie-Tooth Disease Type 2A Caused by Mutation in a Microtubule Motor KIF1Bβ
Zhao, C., Takita, J., Tanaka, Y., Setou, M., Nakagawa, T., Takeda, S., Yang, H. W., Terada, S., Nakata, T., Takei, Y., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00363-4 · Cited by 765
Mutations in Dynein Link Motor Neuron Degeneration to Defects in Retrograde Transport
Hafezparast, M., Klocke, R., Ruhrberg, C., Marquardt, A., Ahmad‐Annuar, A., Bowen, S., Lalli, G., Witherden, A. S., Hummerich, H., Nicholson, S. J., et al. (2003) · Science · doi:10.1126/science.1083129 · Cited by 684
Axonal Self-Destruction and Neurodegeneration
Raff, M., Whitmore, A., & Finn, J. (2002) · Science · doi:10.1126/science.1068613 · Cited by 670
Absence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve
Lunn, E. R., Perry, V. H., Brown, M. C., Rosen, H., & Gordon, S. (1989) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1989.tb00771.x · Cited by 646
Toward an understanding of the molecular mechanisms of physiological cell death.
Vaux, D. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.786 · Cited by 615
Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene
Mack, T. G. A., Reiner, M., Beirowski, B., Mi, W., Emanuelli, M., Wagner, D., Thomson, D., Gillingwater, T., Court, F., Conforti, L., et al. (2001) · Nature Neuroscience · doi:10.1038/nn770 · Cited by 611
Self-citationIn vivo imaging of axonal degeneration and regeneration in the injured spinal cord
Kerschensteiner, M., Schwab, M. E., Lichtman, J. W., & Misgeld, T. (2005) · Nature Medicine · doi:10.1038/nm1229 · Cited by 582
β-Amyloid precursor protein (βAPP) as a marker for axonal injury after head injury
Gentleman, S. M., Nash, M. J., Sweeting, C. J., Graham, D. I., & Roberts, G. W. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90398-5 · Cited by 570
Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches
Tsai, J., Grutzendler, J., Duff, K., & Gan, W.-B. (2004) · Nature Neuroscience · doi:10.1038/nn1335 · Cited by 561
A Kinesin Heavy Chain (KIF5A) Mutation in Hereditary Spastic Paraplegia (SPG10)
Reid, E., Kloos, M. T., Ashley‐Koch, A. E., Hughes, L., Bevan, S., Svenson, I. K., Graham, F. L., Gaskell, P. C., Dearlove, A., Pericak‐Vance, M. A., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/344210 · Cited by 540
Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice
Saigoh, K., Wang, Y., Suh, J., Yamanishi, T., Sakai, Y., Kiyosawa, H., Harada, T., Ichihara, N., Wakana, S., Kikuchi, T., et al. (1999) · Nature Genetics · doi:10.1038/12647 · Cited by 501
Axonal damage: a key predictor of outcome in human CNS diseases
Medana, I. M., & Esiri, M. M. (2003) · Brain · doi:10.1093/brain/awg061 · Cited by 465
Craner, M. J., Newcombe, J., Black, J. A., Hartle, C., Cuzner, M. L., & Waxman, S. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402765101 · Cited by 446
Galvin, J. E., Uryu, K., Lee, V. M. ‐., & Trojanowski, J. Q. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13450 · Cited by 430
On the degeneration of rat neuromuscular junctions after nerve section
Miledi, R., & Slater, C. R. (1970) · The Journal of Physiology · doi:10.1113/jphysiol.1970.sp009076 · Cited by 425
Axon pathology in neurological disease: a neglected therapeutic target
Coleman, M. P., & Perry, V. H. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02255-5 · Cited by 387
Self-citationULTRASTRUCTURAL STUDIES OF THE DYING-BACK PROCESS
Schaumburg, H. H., Wı́sniewski, H. M., & Spencer, P. S. (1974) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-197404000-00006 · Cited by 366
He, L., Li, S.-H., Yu, Z.-X., Shelbourne, P., & Li, X. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08473.2001 · Cited by 359
Susceptibility to Neurodegeneration in a Glaucoma Is Modified by Bax Gene Dosage
Libby, R. T., Li, Y., Savinova, O. V., Barter, J. W., Smith, R. S., Nickells, R. W., & John, S. W. M. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010004 · Cited by 358
A local mechanism mediates NAD-dependent protection of axon degeneration
Wang, J., Zhai, Q., Chen, Y., Lin, E., Gu, W., McBurney, M. W., & He, Z. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200504028 · Cited by 352
Edgar, J. M., McLaughlin, M., Yool, D., Zhang, S.-C., Fowler, J. H., Montague, P., Barrie, J. A., McCulloch, M. C., Duncan, I. D., Garbern, J., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200312012 · Cited by 328
Involvement of the Ubiquitin-Proteasome System in the Early Stages of Wallerian Degeneration
Zhai, Q., Wang, J., Kim, A., Liu, Q., Watts, R. J., Hoopfer, E. D., Mitchison, T. J., Luo, L., & He, Z. (2003) · Neuron · doi:10.1016/s0896-6273(03)00429-x · Cited by 322
General mechanisms of axonal damage and its prevention
Stys, P. K. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.031 · Cited by 314
Beirowski, B., Adalbert, R., Wagner, D. A., Grumme, D., Addicks, K., Ribchester, R. R., & Coleman, M. P. (2005) · BMC Neuroscience · doi:10.1186/1471-2202-6-6 · Cited by 303
Self-citationStys, P. K. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199801000-00002 · Cited by 286
Ultrastructural Studies of the Dying-Back Process
Spencer, P. S., & Schaumburg, H. H. (1977) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-197703000-00005 · Cited by 272
Blockers of sodium and calcium entry protect axons from nitric oxide‐mediated degeneration
Kapoor, R., Davies, M., Blaker, P. A., Hall, S. M., & Smith, K. J. (2002) · Annals of Neurology · doi:10.1002/ana.10443 · Cited by 252
Conforti, L., Tarlton, A., Mack, T. G. A., Mi, W., Buckmaster, E. A., Wagner, D., Perry, V. H., & Coleman, M. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.21.11377 · Cited by 251
Self-citationErythropoietin both protects from and reverses experimental diabetic neuropathy
Bianchi, R., Büyükakıllı, B., Brines, M. L., Savino, C., Cavaletti, G., Oggioni, N., Lauria, G., Borgna, M., Lombardi, R., Çimen, B., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307823100 · Cited by 247
Webster, H. D. (1962) · The Journal of Cell Biology · doi:10.1083/jcb.12.2.361 · Cited by 245
Functional Fluorescent Ca2+ Indicator Proteins in Transgenic Mice under TET Control
Hasan, M. T., Friedrich, R. W., Euler, T., Larkum, M. E., Giese, G., Both, M., Duebel, J., Waters, J., Bujard, H., Griesbeck, O., et al. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020163 · Cited by 242
Finn, J. T., Weil, M., Archer, F., Siman, R., Srinivasan, A. N., & RAFF, M. C. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-04-01333.2000 · Cited by 241
Craner, M. (2004) · Brain · doi:10.1093/brain/awh032 · Cited by 235
Adle‐Biassette, Chrétien, Wingertsmann, Hery, H., Ereau, Scaravilli, Tardieu, & Gray (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00167.x · Cited by 233
Iwata, A., Stys, P., Wolf, J., Chen, X.-H., Taylor, A. G., Meaney, D., & Smith, D. H. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0515-03.2004 · Cited by 233
Ferri, A., Sanes, J. R., Coleman, M. P., Cunningham, J. M., & Kato, A. C. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00206-9 · Cited by 221
Self-citationCalcium-induced degeneration of axoplasm in isolated segments of rat peripheral nerve
Schlaepfer, W. W. (1974) · Brain Research · doi:10.1016/0006-8993(74)90002-x · Cited by 212
Neurofilament functions in health and disease
Julien, J. (1999) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(99)00004-5 · Cited by 209
Sagot, Y., Dubois‐Dauphin, M., Tan, S., de Bilbao, F., Aebischer, P., Martinou, J., & Kato, A. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-11-07727.1995 · Cited by 201
An 85-kb tandem triplication in the slow Wallerian degeneration ( Wld s ) mouse
Coleman, M. P., Conforti, L., Buckmaster, E. A., Tarlton, A., Ewing, R. M., Brown, M. C., Lyon, M. F., & Perry, V. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9985 · Cited by 193
Self-citationEarly course of wallerian degeneration in myelinated fibres of the rat phrenic nerve
Lubińska, L. (1977) · Brain Research · doi:10.1016/0006-8993(77)90841-1 · Cited by 192
Axonal protection using flecainide in experimental autoimmune encephalomyelitis
Bechtold, D. A., Kapoor, R., & Smith, K. J. (2004) · Annals of Neurology · doi:10.1002/ana.20045 · Cited by 192
Ouardouz, M., Nikolaeva, M. A., Coderre, E., Zamponi, G. W., McRory, J. E., Trapp, B. D., Yin, X., Wang, W., Woulfe, J., & Stys, P. K. (2003) · Neuron · doi:10.1016/j.neuron.2003.08.016 · Cited by 191
Brendza, R. P., Bacskai, B. J., Cirrito, J. R., Simmons, K. A., Skoch, J. M., Klunk, W. E., Mathis, C. A., Bales, K. R., Paul, S. M., Hyman, B. T., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23269 · Cited by 190
Microanatomy of Axon/Glial Signaling during Wallerian Degeneration
Guertin, A. D., Zhang, D. P., Mak, K. S., Alberta, J. A., & Kim, H. A. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3766-04.2005 · Cited by 188
Kornek, B. (2001) · Brain · doi:10.1093/brain/124.6.1114 · Cited by 185
Mechanism of Calcium Entry during Axon Injury and Degeneration
LoPachin, R. M., & Lehning, E. J. (1997) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1997.8106 · Cited by 162
Perry, V. H., Brown, M. C., Lunn, E. R., Tree, P., & Gordon, S. (1990) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1990.tb00472.x · Cited by 161
A missense mutation in Tbce causes progressive motor neuronopathy in mice
Martín, N., Jaubert, J., Gounon, P., SALIDO, E. C., Haase, G., Szatanik, M., & Guénet, J. (2002) · Nature Genetics · doi:10.1038/ng1016 · Cited by 159
Samsam, M., Mi, W., Wessig, C., Zielasek, J., Toyka, K. V., Coleman, M. P., & Martini, R. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02833.2003 · Cited by 153
Self-citationCNP is required for maintenance of axon-glia interactions at nodes of Ranvier in the CNS
Rasband, M. N., Tayler, J. E., Kaga, Y., Yang, Y., Lappe-Siefke, C., Nave, K., & Bansal, R. (2005) · Glia · doi:10.1002/glia.20165 · Cited by 152
Deckwerth, T. L., & Johnson, E. M. (1994) · Developmental Biology · doi:10.1006/dbio.1994.1234 · Cited by 152
The 'dying back' process. A common denominator in many naturally occurring and toxic neuropathies.
Jb, C. (1979) · PubMed · Cited by 151
Glial cells are increased proportionally in transgenic optic nerves with increased numbers of axons
Burne, J. F., Staple, J., & RAFF, M. C. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-06-02064.1996 · Cited by 151
A novel endogenous erythropoietin mediated pathway prevents axonal degeneration
Keswani, S. C., Buldanlioğlu, U., Fischer, A., Reed, N., Polley, M., Hong, L. L., Zhou, C., Jack, C., Leitz, G. J., & Höke, A. (2004) · Annals of Neurology · doi:10.1002/ana.20285 · Cited by 150
Wlds mice are resistant to paclitaxel (taxol) neuropathy
Wang, M. S., Davis, A. A., Culver, D. G., & Glass, J. D. (2002) · Annals of Neurology · doi:10.1002/ana.10300 · Cited by 146
Stone, J. R., Okonkwo, D. O., Diallo, A. O., Rubin, D. G., Mutlu, L. K., Povlishock, J. T., & Helm, G. A. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.022 · Cited by 145
Wlds-Mediated Protection of Dopaminergic Fibers in an Animal Model of Parkinson Disease
Sajadi, A., Schneider, B. L., & Aebischer, P. (2004) · Current Biology · doi:10.1016/j.cub.2004.01.053 · Cited by 142
Structural alterations of peripheral nerve induced by the calcium ionophore A23187
Schlaepfer, W. W. (1977) · Brain Research · doi:10.1016/0006-8993(77)90126-3 · Cited by 142
Glass, J. D., Brushart, T. M. E., George, E. B., & Griffin, J. W. (1993) · Journal of Neurocytology · doi:10.1007/bf01195555 · Cited by 140
Drug development for stroke: importance of protecting cerebral white matter
Dewar, D., Yam, P. S., & McCulloch, J. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00280-0 · Cited by 126
Focal Lesions in the Rat Central Nervous System Induced by Endothelin-1
Hughes, P., Anthony, D. C., Rudin, M., Botham, M. S., Rankine, E. L., Sablone, M., Kindler, D., Mir, A. K., & Perry, V. H. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.12.1276 · Cited by 124
Beirowski, B., Berek, L., Adalbert, R., Wagner, D. A., Grumme, D., Addicks, K., Ribchester, R. R., & Coleman, M. P. (2003) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2003.10.016 · Cited by 122
Self-citationFern, R. F., Ransom, B. R., Stys, P. K., & Waxman, S. G. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39449-8 · Cited by 118
Calpain inhibition protects against Taxol-induced sensory neuropathy
Wang, M. S. (2003) · Brain · doi:10.1093/brain/awh078 · Cited by 116
The WldS gene modestly prolongs survival in the SOD1G93A fALS mouse
Fischer, L. R., Culver, D. G., Davis, A. A., Tennant, P., Wang, M.-S., Coleman, M. P., Asress, S., Adalbert, R., Alexander, G. M., & Glass, J. D. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.01.008 · Cited by 115
Self-citationMi, W. (2004) · Brain · doi:10.1093/brain/awh368 · Cited by 115
The effect of myelinating Schwann cells on axons
Martini, R. (2001) · Muscle & Nerve · doi:10.1002/mus.1027 · Cited by 113
The spatio-temporal pattern of Wallerian degeneration in mammalian peripheral nerves
Donat, J. R., & ́niewski, H. M. W. (1973) · Brain Research · doi:10.1016/0006-8993(73)90765-8 · Cited by 110
Bouldin, T. W., & Cavanagh, J. (1979) · PubMed · Cited by 108
Ikegami, K., & Koike, T. (2003) · Neuroscience · doi:10.1016/j.neuroscience.2003.08.057 · Cited by 105
Gillingwater, T. H., Thomson, D., Mack, T. G. A., Soffin, E. M., Mattison, R. J., Coleman, M. P., & Ribchester, R. R. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.022343 · Cited by 91
Self-citationHains, B. C., Saab, C. Y., Lo, A., & Waxman, S. G. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.04.001 · Cited by 90
Adalbert, R., Gillingwater, T. H., Haley, J. E., Bridge, K., Beirowski, B., Berek, L., Wagner, D. A., Grumme, D., Thomson, D., Çelik, A., et al. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03833.x · Cited by 87
Self-citationThe proximo-distal spread of axonal degeneration in the dorsal columns of the rat
George, R., & Griffin, J. W. (1994) · Journal of Neurocytology · doi:10.1007/bf01181641 · Cited by 83
Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis
Lo, A., Black, J. A., & Waxman, S. G. (2002) · Neuroreport · doi:10.1097/00001756-200210280-00015 · Cited by 83
The proapoptotic proteins Bax and Bak are not involved in Wallerian degeneration
Whitmore, A. V., Lindsten, T., RAFF, M. C., & Thompson, C. B. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401147 · Cited by 82
Berliocchi, L., Fava, E., Leist, M., Horvat, V., Dinsdale, D. D., Read, D., & Nicotera, P. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200406126 · Cited by 82
Lunn, E. R., Brown, M. C., & Perry, V. H. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90130-v · Cited by 81
Raja, F., Sherriff, F. E., Morris, C. S., Bridges, L., & Esiri, M. M. (1997) · Acta Neuropathologica · doi:10.1007/s004010050601 · Cited by 78
The gene for slow Wallerian degeneration (Wld(s)) is also protective against vincristine neuropathy.
Wang, M.-S., Wu, Y., Culver, D. G., & Glass, J. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0334 · Cited by 77
The Neuroprotective Factor Wlds Does Not Attenuate Mutant SOD1-Mediated Motor Neuron Disease
Velde, C. V., Garcia, M. L., Yin, X., Trapp, B. D., & Cleveland, D. W. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:5:3:193 · Cited by 77
Sievers, C., Platt, N., Perry, V. H., Coleman, M. P., & Conforti, L. (2003) · Neuroscience Research · doi:10.1016/s0168-0102(03)00039-7 · Cited by 76
Self-citationChanges at the nodes of ranvier during wallerian degeneration: an electron microscope study
Ballin, R. H. M., & Thomas, P. K. (1969) · Acta Neuropathologica · doi:10.1007/bf00685303 · Cited by 75
Calcium channel blockers ameliorate disease in a mouse model of multiple sclerosis
Brand‐Schieber, E., & Werner, P. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.023 · Cited by 73
Bechtold, D. A. (2004) · Brain · doi:10.1093/brain/awh328 · Cited by 73
Sasaki, S., Warita, H., Abe, K., & Iwata, M. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1021-9 · Cited by 72
Ichihara, N., Wu, J., Hua Chui, D., Yamazaki, K., Wakabayashi, T., & Kikuchi, T. (1995) · Brain Research · doi:10.1016/0006-8993(95)00729-a · Cited by 70
Neuroprotection after Transient Global Cerebral Ischemia in Wld s Mutant Mice
Gillingwater, T. H., Haley, J. E., Ribchester, R. R., & Horsburgh, K. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000095798.98378.34 · Cited by 68
MacInnis, B. L., & Campenot, R. B. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2004.10.003 · Cited by 67
Erythropoietin is neuroprotective in models of HIV sensory neuropathy
Keswani, S. C., Leitz, G. J., & Höke, A. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.08.080 · Cited by 67
Deconstructing the axon: Wallerian degeneration and the ubiquitin–proteasome system
Ehlers, M. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.10.015 · Cited by 66
Buckmaster, E. A., Perry, V. H., & Brown, M. C. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb01155.x · Cited by 59
Neuroaxonal pathology in Creutzfeldt-Jakob disease
Liberski, P. P., & Budka, H. (1999) · Acta Neuropathologica · doi:10.1007/s004010050995 · Cited by 53
Axonal degeneration in multiple sclerosis: Is it time for neuroprotective strategies?
Stys, P. K. (2004) · Annals of Neurology · doi:10.1002/ana.20082 · Cited by 52
Wallerian Degeneration Involves Rho/Rho-kinase Signaling
Yamagishi, S., Fujitani, M., Hata, K., Kitajo, K., Mimura, F., Abe, H., & Yamashita, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501945200 · Cited by 42
Cheng, C. L. Y., & Povlishock, J. T. (1988) · Journal of Neurotrauma · doi:10.1089/neu.1988.5.47 · Cited by 42
Evidence of axonal damage in human acute demyelinating diseases
Ghosh, N., DeLuca, G. C., & Esiri, M. M. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.03.032 · Cited by 41
Programmed Axon Death, Synaptic Dysfunction and the Ubiquitin Proteasome System
Coleman, M. P., & Ribchester, R. R. (2004) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007043337436 · Cited by 40
Self-citationChanges in intra‐axonal calcium distribution following nerve crush
Mata, M. M., Staple, J. K., & Fink, D. J. (1986) · Journal of Neurobiology · doi:10.1002/neu.480170508 · Cited by 40
Sodium channel blockers and axonal protection in neuroinflammatory disease
Waxman, S. G. (2004) · Brain · doi:10.1093/brain/awh353 · Cited by 34
The cellular distribution of the Wlds chimeric protein and its constituent proteins in the CNS
Fang, C., Bernardes-Silva, M., Coleman, M. P., & Perry, V. H. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.06.078 · Cited by 27
Self-citationNeuroprotective strategies in MS: Lessons from C57BL/WldS mice
Coleman, M. P., Adalbert, R., & Beirowski, B. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.028 · Cited by 24
Self-citationIkegami, K., Kato, S., & Koike, T. (2004) · Brain Research · doi:10.1016/j.brainres.2004.09.050 · Cited by 22
Use of YFP to study amyloid-β associated neurite alterations in live brain slices
Brendza, R. P. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.04.008 · Cited by 21
Schwab, C., Steele, J. C., & McGeer, P. L. (1997) · Acta Neuropathologica · doi:10.1007/s004010050737 · Cited by 18
Nerve destruction by colchicine resulting in suppression of limb regeneration in adult triturus
Singer, M., Flinker, D., & Sidman, R. L. (1956) · Journal of Experimental Zoology · doi:10.1002/jez.1401310306 · Cited by 12
The node of ranvier in early wallerian degeneration: A freeze-fracture study
Abrahams, P., Day, A., & Allt, G. (1981) · Acta Neuropathologica · doi:10.1007/bf00689401 · Cited by 12
Nolte (2001) · doi:10.1002/1098-1136(20010101)33:1
Flagged first, then by citations
Research works printed but not linked: 1
- Wishart, T. M. et al. Transcriptional regulation of pituitary tumour transforming gene-1 by the neuroprotective WldS gene in mouse cerebellar granule cells and HEK293 cell lines. J. Physiol. 565P, C74 (2004).
Cited by
Sorted by citations
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y., Jiang, Q. L., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,351
Ying, W. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1672 · Cited by 1,494
The cholinergic system in aging and neuronal degeneration
Schliebs, R., & Arendt, T. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.11.058 · Cited by 1,047
Clinical progression in Parkinson disease and the neurobiology of axons
Cheng, H., Ulane, C. M., & Burke, R. E. (2010) · Annals of Neurology · doi:10.1002/ana.21995 · Cited by 1,012
The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways
Houtkooper, R. H., Cantó, C., Wanders, R. J., & Auwerx, J. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0026 · Cited by 899
Metadata
- Authors
- Coleman, M.
- Affiliations
- Babraham Institute (GB)
- Corresponding author
- Coleman, Michael
- ORCID
- Coleman, Michael
- Venue
- Nature reviews. Neuroscience
- Published
- 2005-10-14
- Volume
- 6
- Issue
- 11
- Pages
- 889-898
- ISSN
- 1471-003X (ISSN-L)
- 1471-0048
- OpenAlex
- W2042991032
- Cited by
- 819
- References
- 122
- Citations by year
- 2026: 15 · 2025: 30 · 2024: 13 · 2023: 22 · 2022: 18 · 2021: 35 · 2020: 40 · 2019: 32 · 2018: 40 · 2017: 48 · 2016: 43 · 2015: 51 · 2014: 47 · 2013: 58 · 2012: 53
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Biotechnology and Biological Sciences Research Council
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- axonal degeneration, Wallerian degeneration, axonal transport, mitochondrial dysfunction, intracellular calcium, sodium influx, calcium influx
- MeSH terms
- Animals, Axons, Axonal Transport, Central Nervous System, Humans, Nerve Tissue Proteins, Wallerian Degeneration
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review